Cms Cameron Mckenna Nabarro Olswang Llp Analysis

LAW FIRM ANALYSIS

Latest European patent oppositions filed by Cms Cameron Mckenna Nabarro Olswang Llp

Patent:
Title:
Compositions Comprising A Delivery Agent And Preparation Thereof
Opposition Date:
2024-06-13
Patent:
Title:
Inhibition Of Hsd17B13 In The Treatment Of Liver Disease In Patients Expressing The Pnpla3 I148M Variation
Opposition Date:
2023-12-08
Patent:
Title:
Methods And Compositions For Efficient Delivery Of Nucleic Acids And Rna-Based Antimicrobials
Opposition Date:
2023-10-30
Patent:
Title:
Uses Of Neuregulin In Preventing, Treating Or Delaying Ventricular Arrhythmia, And Composition Thereof
Opposition Date:
2023-01-13
Patent:
Title:
Live Cell Constructs For Production Of Cultured Milk Product And Methods Using The Same
Applicant:
Opposition Date:
2022-11-09
Patent:
Title:
Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)
Opposition Date:
2022-10-12
Patent:
Title:
Antibody Producing Non-Human Mammals
Applicant:
Opposition Date:
2022-08-19
Patent:
Title:
Combination Medicament Comprising Il-12 And An Agent For Blockade Of T-Cell Inhibitory Molecules For Tumour Therapy
Opposition Date:
2022-03-02
Patent:
Title:
Point-Of-Care And/Or Portable Platform For Gene Therapy
Opposition Date:
2022-02-03
Patent:
Title:
Transgenic Mouse Which Produces Hybrid Antibodies Containing Human Variable Regions And Mouse Constant Regions
Opposition Date:
2021-12-22